The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date

Osteoarthritis (OA) is a complex heterogeneous articular disease with multiple joint tissue involvement of varying severity and no regulatory-agency-approved disease-modifying drugs (DMOADs). In this review, we discuss the reasons necessitating the development of DMOADs for OA management, the classi...

Descripción completa

Detalles Bibliográficos
Autores principales: Oo, Win Min, Little, Christopher, Duong, Vicky, Hunter, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273751/
https://www.ncbi.nlm.nih.gov/pubmed/34262259
http://dx.doi.org/10.2147/DDDT.S295224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273751/
https://www.ncbi.nlm.nih.gov/pubmed/34262259
http://dx.doi.org/10.2147/DDDT.S295224

Ejemplares similares